Not checked for notices yet.
Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
Alison M. Kurimchak, Claude Shelton, Kelly E. Duncan and 13 more
Cell Reports · 2016
doi:10.1016/j.celrep.2016.06.091
Cited by papers we hold 4
- Targeted protein degradation: advances in drug discovery and clinical practice · 2024No notice
- Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy · 2023No notice
- Achieving clinical success with BET inhibitors as anti-cancer agents · 2021No notice
- Alternative approaches to target Myc for cancer treatment · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.